Back

Impact of P2Y12 inhibitor pretreatment on baseline TIMI flow and short-term outcomes in STEMI patients undergoing primary PCI: a 10-year single-center study

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Pharmacotherapy to improve outcomes in coronary disease Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Dragana Dabovic

Faculty of Medicine University Novi Sad, Novi Sad (Serbia)

7 More presentations in this session

Presentation thumbnail
Predicting individualized treatment effects of prasugrel vs ticagrelor for acute coronary syndrome: a post hoc analysis of a randomized clinical trial
Doctor N. Kruger (Boston, US)
Abstract
Presentation thumbnail
AZD0780, a novel, oral PCSK9 inhibitor with properties allowing for broad use, food-intake independency and co-administration with other lipid lowering therapies
Doctor J. Rosenmeier (Gothenburg, SE)
Abstract Slides Video
Presentation thumbnail
Side effects of low-dose colchicine in chronic coronary syndromes, the LoDoCo2 trial
Miss J. Jannink (Utrecht, NL)
Abstract Slides Video
Presentation thumbnail
Colchicine in patients with recent myocardial infarction: a systematic review and meta-analysis of randomized controlled trials
Ms A. Moiz (Montreal, CA)
Abstract Slides Video
Presentation thumbnail
PCSK-9 inhibitors vs. ezetimibe for secondary prevention: utilization disparities and clinical outcomes
Doctor M. Sghayyer (Birmingham, US)
Abstract Slides Video

Access the full session

Session thumbnail
Pharmacotherapy to improve outcomes in coronary disease

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Effect of P2Y12 pretreatment on angiographic findings and in-hospital mortality in patients with ST-elevation myocardial infarction
thumbnail
Congress Presentation
Pretreatment with P2Y12 inhibitors and relationship with clinical outcomes in NSTEMI: Analysis of 2 Argentinian registries
thumbnail
Congress Presentation
Impact of pretreatment with P2Y12 receptor inhibitors on type 4a myocardial infarction and bleeding in patients with non-ST-segment elevation myocardial infarction: a propensity score matching study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources